Martin Pulé
Founder at AUTOLUS THERAPEUTICS PLC
Net worth: 4 M $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Martin Murphy | M | 55 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
Christian Martin Itin | M | 59 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
John Berriman | M | 76 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
Cynthia Butitta | F | 70 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 6 years |
Joseph Anderson | M | 65 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 8 years |
Kapil Dhingra | M | 64 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
Linda Bain | F | 53 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 6 years |
David Brochu | M | - | 5 years | |
Olivia Manser | F | - | 2 years | |
Alexander Swan | M | - | 3 years | |
Alex Driggs | M | 48 | - | |
Veronica Hersberger | M | - | 1 years | |
Julia Wilson | F | - | - | |
Brent Rice | M | 58 | 3 years | |
Robert Iannone | M | 57 | 1 years | |
Christopher Vann | M | 59 | 8 years | |
Elisabeth Leiderman | M | 47 | 1 years | |
Robert Azelby | M | 56 | - | |
William Young | M | 79 | 3 years | |
Robert Dolski | M | 54 | 1 years | |
Miranda Neville | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lucinda Crabtree | M | 45 | 3 years | |
Matthias Alder | M | 59 | 4 years | |
John Johnson | M | 66 | 3 years | |
Jay Backstrom | M | 69 | 3 years | |
Andrew Oakley | M | 62 | 4 years | |
Vijay Reddy Peddareddigari | M | 52 | 4 years | |
Neil Bell | M | 67 | 3 years | |
Adam Hacker | M | 55 | 3 years | |
Vishal Mehta | M | - | 3 years | |
Nushmia Khokhar | M | - | - | |
Edgar Braendle | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 32 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Pulé
- Personal Network